SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-18-001497
Filing Date
2018-03-12
Accepted
2018-03-12 08:18:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 a2234809zs-3.htm S-3 452671
2 EX-5.1 a2234809zex-5_1.htm EX-5.1 39564
3 EX-23.1 a2234809zex-23_1.htm EX-23.1 2647
4 G21153.JPG g21153.jpg GRAPHIC 32052
  Complete submission text file 0001047469-18-001497.txt   540191
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: S-3 | Act: 33 | File No.: 333-223576 | Film No.: 18682124
SIC: 2834 Pharmaceutical Preparations